{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:27:31Z","timestamp":1788827251352,"version":"build-2803163510"},"reference-count":30,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"unspecified","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,11,9]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sarcoidosis is a systemic granulomatous disease with an unpredictable course. While corticosteroids are the mainstay of treatment, recurrence is common and influenced by clinical, demographic and therapeutic factors. However, an integrated approach to patient stratification remains underdeveloped.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research question<\/jats:title>\n                    <jats:p>What are the key clinical, demographic and therapeutic factors influencing sarcoidosis recurrence, and how can an integrated risk stratification model improve disease management?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a clustering analysis on 160 sarcoidosis patients to identify recurrence risk subgroups. Key variables included age, sex, body mass index, smoking history, Scadding stage, corticosteroid and immunosuppressant use, therapy duration and recurrence. K-means clustering was employed, with the optimal number of clusters determined using silhouette and elbow methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three distinct clusters emerged: Cluster 1 (n=110): predominantly Scadding stage I\u2013II, low recurrence, favourable steroid response, minimal long-term complications. Cluster 0 (n=30): more smokers, advanced disease (Scadding III\u2013IV), high recurrence despite treatment (p=0.003). Cluster 2 (n=20): patients with obesity with systemic symptoms (fatigue, dyspnoea), high recurrence, particularly in women (p=0.02).<\/jats:p>\n                    <jats:p>Multivariate analysis confirmed smoking (OR 2.3, p=0.002), obesity (OR 1.9, p=0.01) and prolonged steroid use (&gt;12 months, OR 2.5, p=0.004) as independent predictors of recurrence. Sex differences were observed, with women showing more extrapulmonary involvement and men a higher risk of pulmonary fibrosis, though sex alone was not a significant predictor (p=0.08).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>Distinct sarcoidosis phenotypes influence recurrence risk, underscoring the need for personalised management. While Cluster 1 may achieve remission with minimal therapy, Clusters 0 and 2 highlight smoking, obesity and advanced disease as recurrence drivers. Targeted interventions, including smoking cessation, weight management and early steroid-sparing therapy, could improve long-term outcomes and reduce disease burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003495","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:45:16Z","timestamp":1770651916000},"page":"e003495","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Sarcoidosis relapse risk factors: a single-centre retrospective cluster analysis"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7699-6610","authenticated-orcid":false,"given":"Francesco","family":"Bertuccio","sequence":"first","affiliation":[{"name":"Respiratory Unit, IRCCS Policlinico San Matteo, Pavia, Italy"},{"name":"Universit\u00e0 degli Studi di Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Piloni","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi di Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachiara","family":"Crescenzi","sequence":"additional","affiliation":[{"name":"Respiratory Unit, IRCCS Policlinico San Matteo, Pavia, Italy"},{"name":"Universit\u00e0 degli Studi di Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady","family":"Tousa","sequence":"additional","affiliation":[{"name":"Respiratory Unit, IRCCS Policlinico San Matteo, Pavia, Italy"},{"name":"Universit\u00e0 degli Studi di Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Putignano","sequence":"additional","affiliation":[{"name":"Ospedale Maggiore di Crema, Crema, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Russo","sequence":"additional","affiliation":[{"name":"Respiratory Unit, IRCCS Policlinico San Matteo, Pavia, Italy"},{"name":"Universit\u00e0 degli Studi di Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Marag\u00f2","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi di Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Guido","family":"Corsico","sequence":"additional","affiliation":[{"name":"Respiratory Unit, IRCCS Policlinico San Matteo, Pavia, Italy"},{"name":"Universit\u00e0 degli Studi di Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Maria","family":"Stella","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi di Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"2026020907450767000_13.1.e003495.1","article-title":"Incidence and Baseline Characteristics of Relapse or Exacerbation in Patients with Pulmonary Sarcoidosis in Japan","volume":"38","author":"Murata","year":"2021","journal-title":"Sarcoidosis, Vasc Diffus Lung Dis Off J WASOG"},{"key":"2026020907450767000_13.1.e003495.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00138913"},{"key":"2026020907450767000_13.1.e003495.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071714"},{"key":"2026020907450767000_13.1.e003495.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12888-7"},{"key":"2026020907450767000_13.1.e003495.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00105805"},{"key":"2026020907450767000_13.1.e003495.6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"key":"2026020907450767000_13.1.e003495.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.3.623"},{"key":"2026020907450767000_13.1.e003495.8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2003.01076.x"},{"key":"2026020907450767000_13.1.e003495.9","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04507-3"},{"key":"2026020907450767000_13.1.e003495.10","doi-asserted-by":"crossref","first-page":"787681","DOI":"10.3389\/fmed.2021.787681","article-title":"Neutrophils in Bronchoalveolar Lavage Fluid Indicating the Severity and Relapse of Pulmonary Sarcoidosis","volume":"8","author":"Feng","year":"2021","journal-title":"Front Med"},{"key":"2026020907450767000_13.1.e003495.11","unstructured":"Gavrysyuk V , Merenkova I , Vlasova N , et al . CLINICAL FACTORS ASSOCIATED WITH THE RISK OF PULMONARY SARCOIDOSIS RELAPSE. Georgian Med News 2021;84\u20138."},{"key":"2026020907450767000_13.1.e003495.12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MCP.0000000000000077","article-title":"Clinical phenotypes in sarcoidosis","volume":"20","author":"Pereira","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"2026020907450767000_13.1.e003495.13","first-page":"34","article-title":"Factor Analysis of Sarcoidosis Phenotypes at Two Referral Centers in Brazil","volume":"28","author":"Rodrigues","year":"2011","journal-title":"Sarcoidosis, Vasc Diffus Lung Dis Off J WASOG"},{"key":"2026020907450767000_13.1.e003495.14","doi-asserted-by":"publisher","DOI":"10.1136\/thx.43.7.516"},{"key":"2026020907450767000_13.1.e003495.15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1749-6632.1986.tb18541.x","article-title":"Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis","volume":"465","author":"Hance","year":"1986","journal-title":"Ann N Y Acad Sci"},{"key":"2026020907450767000_13.1.e003495.16","doi-asserted-by":"crossref","first-page":"106688","DOI":"10.1016\/j.rmed.2021.106688","article-title":"Differences in disease presentation between men and women with sarcoidosis: A cohort study","volume":"191","author":"Lundkvist","year":"2022","journal-title":"Respir Med"},{"key":"2026020907450767000_13.1.e003495.17","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/236905","article-title":"Sarcoidosis: sex-dependent variations in presentation and management","volume":"2014","author":"Birnbaum","year":"2014","journal-title":"J Ophthalmol"},{"key":"2026020907450767000_13.1.e003495.18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1183\/23120541.00492-2022","article-title":"Modifiable lifestyle risk factors for sarcoidosis: a nested case-control study","volume":"9","author":"Dehara","year":"2023","journal-title":"ERJ Open Res"},{"key":"2026020907450767000_13.1.e003495.19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.11648\/j.ajim.20200805.18","article-title":"Association Between Obesity and Sarcoidosis: A Systematic Review and Meta-analysis","volume":"8","author":"Wainaina Wambui","year":"2020","journal-title":"AJIM"},{"key":"2026020907450767000_13.1.e003495.20","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1099"},{"key":"2026020907450767000_13.1.e003495.21","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946202264071","article-title":"Chronic exposure to cigarette smoke transiently worsens the disease course in a mouse model of pulmonary paracoccidioidomycosis","volume":"64","author":"Buccheri","year":"2022","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2026020907450767000_13.1.e003495.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200202-097OC"},{"key":"2026020907450767000_13.1.e003495.23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1516433","article-title":"Large-scale analysis highlights obesity as a risk factor for chronic, non-communicable inflammatory diseases","volume":"16","author":"Mousavi","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026020907450767000_13.1.e003495.24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/13685538.2019.1631272","article-title":"Is sarcoidosis related to metabolic syndrome and insulin resistance?","volume":"23","author":"Y\u0131ld\u0131z G\u00fclhan","year":"2020","journal-title":"Aging Male"},{"key":"2026020907450767000_13.1.e003495.25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/MCP.0000000000000882","article-title":"The influence of age and sex in sarcoidosis","volume":"28","author":"Singha","year":"2022","journal-title":"Curr Opin Pulm Med"},{"key":"2026020907450767000_13.1.e003495.26","doi-asserted-by":"crossref","unstructured":"Xiong Y , Kullberg S , Garman L , et al . Sex differences in the genetics of sarcoidosis across European and African ancestry populations. Front Med 2023;10. doi:10.3389\/fmed.2023.1132799","DOI":"10.3389\/fmed.2023.1132799"},{"key":"2026020907450767000_13.1.e003495.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.10.003"},{"key":"2026020907450767000_13.1.e003495.28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MCP.0000000000000503","article-title":"Obesity and sarcoidosis: consequence or contributor?","volume":"24","author":"Cozier","year":"2018","journal-title":"Curr Opin Pulm Med"},{"key":"2026020907450767000_13.1.e003495.29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026020907450767000_13.1.e003495.30","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00055213"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:45:19Z","timestamp":1770651919000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,9]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjresp-2025-003495"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003495","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}